People around the world maybe rejoicing at reports that remdesivir becomes the first medicine to have an impact on Covid-19…
Search Results: remdesivir (5)
NanoViricides, Inc. (NYSE American:NNVC) (the Company) reports that clinical trials of its broad-spectrum antiviral drug NV-CoV-2 began on June 17,…
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) a global leader in the development of highly effective antiviral therapies based on a…
New York-listed Eli Lilly and Company announced today that the first patient has been enrolled in a Phase 3 randomized,…
NanoViricides, Inc. (NYSE American: NNVC) (the “Company”) a leader in the development of highly effective antiviral therapies based on a…